FIBROBIOLOGICS INC (FBLG) Stock News

USA - NASDAQ:FBLG - US31573L1052 - Common Stock

0.3679 USD

+0.03 (+9.59%)

Last: 11/14/2025, 4:43:02 PM

0.363 USD

0 (-1.33%)

After Hours: 11/14/2025, 4:43:02 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

FBLG Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Benzinga - Mentions: DERM INTS LPTX CMND ...

12 Health Care Stocks Moving In Wednesday's After-Market Session

8 days ago - By: Benzinga - Mentions: CERS OPRX WORX IRD ...

12 Health Care Stocks Moving In Thursday's After-Market Session

14 days ago - By: FibroBiologics, Inc.

FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

14 days ago - By: FibroBiologics, Inc.

FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

21 days ago - By: FibroBiologics, Inc.

FibroBiologics to Present at Bio-Europe 2025

21 days ago - By: FibroBiologics, Inc.

FibroBiologics to Present at Bio-Europe 2025

a month ago - By: FibroBiologics, Inc.

FibroBiologics to Present at the 2025 ThinkEquity Conference

2 months ago - By: ACCESS Newswire - Mentions: BIVI

BioVie and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

2 months ago - By: FibroBiologics, Inc.

FibroBiologics to Present at 2025 Cell & Gene Meeting on the Mesa

2 months ago - By: FibroBiologics, Inc.

FibroBiologics to Present at 2025 Cell & Gene Meeting on the Mesa

2 months ago - By: FibroBiologics, Inc.

FibroBiologics Leadership Authors Opinion Editorial Highlighting Fibroblast Cells' Therapeutic Advantages Over Traditional Stem Cell Therapies

2 months ago - By: FibroBiologics, Inc.

FibroBiologics Leadership Authors Opinion Editorial Highlighting Fibroblast Cells' Therapeutic Advantages Over Traditional Stem Cell Therapies

2 months ago - By: FibroBiologics, Inc.

FibroBiologics Announces Positive IND-Enabling Updates Demonstrating Potential of Fibroblast Spheroids in Chronic-Relapse Psoriasis Treatment

2 months ago - By: FibroBiologics, Inc.

FibroBiologics Announces Positive IND-Enabling Updates Demonstrating Potential of Fibroblast Spheroids in Chronic-Relapse Psoriasis Treatment

2 months ago - By: FibroBiologics, Inc.

FibroBiologics Announces Significant Advancements in Bone Marrow Organoid Platform Enabling Development for Cancer and Immune-Related Therapies

2 months ago - By: FibroBiologics, Inc.

FibroBiologics Announces Significant Advancements in Bone Marrow Organoid Platform Enabling Development for Cancer and Immune-Related Therapies

3 months ago - By: FibroBiologics, Inc.

FibroBiologics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

3 months ago - By: FibroBiologics, Inc.

FibroBiologics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

4 months ago - By: FibroBiologics, Inc.

FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

4 months ago - By: FibroBiologics, Inc.

FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

4 months ago - By: FibroBiologics, Inc.

FibroBiologics Files Patent for Methods of Generating Multipotent Cells from Donor Tissue for Clinical Applications

4 months ago - By: FibroBiologics, Inc.

FibroBiologics Files Patent for Methods of Generating Multipotent Cells from Donor Tissue for Clinical Applications

4 months ago - By: ACCESS Newswire - Mentions: TBH

Brag House and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

4 months ago - By: FibroBiologics, Inc.

FibroBiologics to Present at the Advanced Wound Care Summit USA

4 months ago - By: FibroBiologics, Inc.

FibroBiologics to Present at the Advanced Wound Care Summit USA

4 months ago - By: FibroBiologics, Inc.

FibroBiologics Confirms Ability to Manufacture CybroCell™ for Degenerative Disc Disease and Cartilage Repair Programs from Existing CYWC628 Master Cell Bank

4 months ago - By: FibroBiologics, Inc.

FibroBiologics’ to Present at Exclusive Live Investor Webinar and Q&A Session on July 10

4 months ago - By: FibroBiologics, Inc.

FibroBiologics’ to Present at Exclusive Live Investor Webinar and Q&A Session on July 10

4 months ago - By: ACCESS Newswire - Mentions: FTHM

Fathom Holdings and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

5 months ago - By: FibroBiologics, Inc.

FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing

5 months ago - By: FibroBiologics, Inc.

FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing

5 months ago - By: FibroBiologics, Inc.

FibroBiologics to Present at the BIO International Convention 2025

5 months ago - By: FibroBiologics, Inc.

FibroBiologics to Present at the BIO International Convention 2025

5 months ago - By: Fibrobiologics, Inc.

FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer

5 months ago - By: Fibrobiologics, Inc.

FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer

6 months ago - By: Fibrobiologics, Inc.

FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting

6 months ago - By: Fibrobiologics, Inc.

FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting

6 months ago - By: Fibrobiologics, Inc.

FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update

6 months ago - By: Fibrobiologics, Inc.

FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update

7 months ago - By: Fibrobiologics, Inc.

FibroBiologics Presents at the ThymUS 2025 Meeting